Home > Insider Trading > Pernix Therapeutics Holdings Inc.

Pernix Therapeutics Holdings Inc. (PTX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 16

Broadfin Capital Initiates Stake in Pernix Therapeutics (PTX)

Last night, Broadfin Capital, a healthcare focused hedge fund managed by Kevin Kotler, disclosed in a Securities and Exchange Commission filing that it has initiated a 3.5 million share position in Pernix...

Keep Reading →

March 6th, 2014 - Hedge Funds News

Edward Gilhuly and Sageview Capital's New Stock Moves

In 2006, Edward Gilhuly and Scott Stuart founded Sageview Capital, an investment firm that has about $800 million in assets under management.

Keep Reading →

February 19th, 2014 - Hedge Funds

Do Hedge Funds and Insiders Love SciClone Pharmaceuticals, Inc. (SCLN)?

In the 21st century investor’s toolkit, there are tons of indicators market participants can use to analyze stocks. A pair of the most innovative are hedge fund and insider trading interest.

Keep Reading →

September 5th, 2013 - News

Is Sucampo Pharmaceuticals, Inc. (SCMP) Going to Burn These Hedge Funds?

According to most stock holders, hedge funds are perceived as slow, old financial tools of the past.

Keep Reading →

July 1st, 2013 - News

Pernix Therapeutics Holdings Inc (PTX): Are Hedge Funds Right About This Stock?

In the financial world, there are plenty of gauges market participants can use to track their holdings. A couple of the most underrated are hedge fund and insider trading activity.

Keep Reading →

July 1st, 2013 - News